Skip to main content
Download PDF

Angiotensin-converting enzyme 2: Possible role in hypertension and kidney disease

Current Hypertension Reports volume 10, pages 70–77 (2008)Cite this article

Abstract

The discovery of angiotensin-converting enzyme (ACE) 2 adds a new level of complexity to the understanding of the renin-angiotensin system. The high catalytic efficiency of ACE2 for the generation of angiotensin (ANG)-1-7 from ANG II suggests an important role of ACE2 in preventing ANG II accumulation, while at the same time enhancing ANG-1-7 formation. ACE and ACE2 may have counterbalancing functions and a regulatory role in fine-tuning the rate at which ANG peptides are formed and degraded. By counterregulating the actions of ACE on ANG II formation, ACE2 may play a role in maintaining a balanced status of the renninangiotensin system. This review focuses on the function of ACE2 and its possible roles in kidney disease and hypertension. Studies using models of ACE2 ablation and the pharmacologic administration of an ACE2 inhibitor suggest that decreased ACE2 activity alone or in combination with increased ACE activity may play a role in both diseases.

References and Recommended Reading

  1. Tipnis SR, Hooper NM, Hyde R, et al.: A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000, 274:33238–33243.

    Article  Google Scholar 

  2. Donoghue M, Hsieh F, Baronas E, et al.: A novel angiotensin-coverting enzyme-related carboxypeptidase (ACE2) converts antiogensin I to angiotensin 1–9. Circ Res 2000, 87:E1–E9.

    PubMed  CAS  Google Scholar 

  3. Towler P, Staker B, Prasad SG, et al.: ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem 2004, 279:17996–18007.

    PubMed  Article  CAS  Google Scholar 

  4. Guy JL, Jackson RM, Acharya KR, et al.: Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry 2003, 42:13185–13192.

    PubMed  Article  CAS  Google Scholar 

  5. Zhang H, Wada J, Hida K, et al.: Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J Biol Chem 2001, 276:17132–17139.

    PubMed  Article  CAS  Google Scholar 

  6. Danilczyk U, Sarao R, Remy C, et al.: Essential role for collectrin in renal amino acid transport. Nature 2006, 444:1088–1091.

    PubMed  Article  CAS  Google Scholar 

  7. Malakauskas SM, Quan H, Fields TA, et al.: Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin. Am J Physiol Renal Physiol 2007, 292:F533–F544.

    PubMed  Article  CAS  Google Scholar 

  8. Zhang Y, Wada J, Yasuhara A, et al.: The role for HNF-1beta-targeted collectrin in maintenance of primary cilia and cell polarity in collecting duct cells. PLoS ONE 2007, 2:e414.

    PubMed  Article  Google Scholar 

  9. Rella M, Elliot JL, Revett TJ, et al.: Identification and characterisation of the angiotensin converting enzyme-3 (ACE3) gene: a novel mammalian homologue of ACE. BMC Genomics 2007, 8:194.

    PubMed  Article  Google Scholar 

  10. Danilczyk U, Penninger JM: Angiotensin-converting enzyme II in the heart and the kidney. Circ Res 2006, 98:463–471.

    PubMed  Article  CAS  Google Scholar 

  11. Kuba K, Imai Y, Rao S, et al.: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 2005, 11:875–879.

    PubMed  Article  CAS  Google Scholar 

  12. Imai Y, Kuba K, Rao S, et al.: Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005, 436:112–116.

    PubMed  Article  CAS  Google Scholar 

  13. Ye M, Wysocki J, Naaz P, et al.: Increased ACE2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 2004, 43:1120–1125.

    PubMed  Article  CAS  Google Scholar 

  14. Soler MJ, Wysocki J, Ye M, et al.: ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int 2007, 72:614–623.

    PubMed  Article  CAS  Google Scholar 

  15. Ye M, Wysocki J, William J, et al.: Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006, 17:3067–3075.

    PubMed  Article  CAS  Google Scholar 

  16. Wysocki J, Ye M, Soler MJ, et al.: ACE and ACE2 activity in diabetic mice. Diabetes 2006, 55:2132–2139.

    PubMed  Article  CAS  Google Scholar 

  17. Vickers C, Hales P, Kaushik V, et al.: Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002, 277:14838–14843.

    PubMed  Article  CAS  Google Scholar 

  18. Su Z, Zimpelmann J, Burns KD: Angiotensin-(1–7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 2006, 69:2212–2218.

    PubMed  Article  CAS  Google Scholar 

  19. Ferrario CM, Jessup J, Gallagher PE, et al.: Effects of renin-angiotensin system blockade on renal angiotensin-(1–7) forming enzymes and receptors. Kidney Int 2005, 68:2189–2196.

    PubMed  Article  CAS  Google Scholar 

  20. Elased KM, Cunha TS, Gurley SB, et al.: New mass spectrometric assay for angiotensin-converting enzyme 2 activity. Hypertension 2006, 47:1010–1017.

    PubMed  Article  CAS  Google Scholar 

  21. Shaltout HA, Westwood BM, Averill DB, et al.: Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol 2007, 292:F82–F91.

    PubMed  Article  CAS  Google Scholar 

  22. Li N, Zimpelmann J, Cheng K, et al.: The role of angiotensin converting enzyme 2 in the generation of angiotensin 1–7 by rat proximal tubules. Am J Physiol Renal Physiol 2005, 288:F353–F362.

    PubMed  Article  CAS  Google Scholar 

  23. Ocaranza MP, Godoy I, Jalil JE, et al.: Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension 2006, 48:572–578.

    PubMed  Article  CAS  Google Scholar 

  24. Ferrario CM, Jessup J, Chappell MC, et al.: Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005, 111:2605–2610.

    PubMed  Article  CAS  Google Scholar 

  25. Burrell LM, Risvanis J, Kubota E, et al.: Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J 2005, 26:369–375.

    PubMed  Article  CAS  Google Scholar 

  26. Donoghue M, Wakimoto H, Maguire CT, et al.: Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins. J Mol Cell Cardiol 2003, 35:1043–1053.

    PubMed  Article  CAS  Google Scholar 

  27. Douglas GC, O’Bryan MK, Hedger MP, et al.: The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis. Endocrinology 2004, 145:4703–4711.

    PubMed  Article  CAS  Google Scholar 

  28. Huang L, Sexton DJ, Skogerson K, et al.: Novel peptide inhibitors of angiotensin-converting enzyme 2. J Biol Chem 2003, 278:15532–15540.

    PubMed  Article  CAS  Google Scholar 

  29. Riviere G, Michaud A, Breton C, et al.: Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat. Hypertension 2005, 46:1169–1174.

    PubMed  Article  CAS  Google Scholar 

  30. Rice GI, Jones AL, Grant PJ, et al.: Circulating activities of angiotensin-converting enzyme, its homolog, angiotensinconverting enzyme 2, and neprilysin in a family study. Hypertension 2006, 48:914–920.

    PubMed  Article  CAS  Google Scholar 

  31. Lambert DW, Yarski M, Warner FJ, et al.: Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem 2005, 280:30313–30319.

    Article  Google Scholar 

  32. Warner FJ, Lew RA, Smith AI, et al.: Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. J Biol Chem 2005, 280:39353–39362.

    PubMed  Article  CAS  Google Scholar 

  33. Tikellis C, Johnston CI, Forbes JM, et al.: Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003, 41:392–397.

    PubMed  Article  CAS  Google Scholar 

  34. Brosnihan KB, Neves LA, Joyner J, et al.: Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy. Hypertension 2003, 42:749–753.

    PubMed  Article  CAS  Google Scholar 

  35. Lely AT, Hamming I, van Goor H, Navis GJ: Renal ACE2 expression in human kidney disease? J Pathol 2004, 204:587–593.

    PubMed  Article  CAS  Google Scholar 

  36. Wysocki J, Soler MJ, Ye M, Batlle D: ACE2 is critically important for angiotensin II metabolism in podocytes. J Am Soc Nephrol 2006, 17:TH-PO877.

    Google Scholar 

  37. Velez JC, Bland AM, Arthur JM, et al.: Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am J Phsiol Renal Physiol 2007, 293:F398–F407.

    Article  CAS  Google Scholar 

  38. Hamming I, Cooper ME, Haagmans BL, et al.: The emerging role of ACE2 in physiology and disease. J Pathol 2007, 212:1–11.

    PubMed  Article  CAS  Google Scholar 

  39. Oudit GY, Herzenberg AM, Kassiri Z, et al.: Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol 2006, 168:1808–1820.

    PubMed  Article  CAS  Google Scholar 

  40. Wong DW, Oudit GY, Reich H, et al.: Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 2007, 171:438–451.

    PubMed  Article  CAS  Google Scholar 

  41. Crackower MA, Sarao R, Oudit GY, et al.: Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002, 417:822–828.

    PubMed  Article  CAS  Google Scholar 

  42. Tikellis C, Cooper ME, Bialkowski K, et al.: Developmental expression of ACE2 in the SHR kidney: a role in hypertension? Kidney Int 2006, 70:34–41.

    PubMed  Article  CAS  Google Scholar 

  43. Zhong J, Yan Z, Liu D, et al.: Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome. J Lab Clin Med 2006, 147:91–95.

    PubMed  Article  CAS  Google Scholar 

  44. Huang W, Yang W, Wang Y, et al.: Association study of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms and essential hypertension in northern Han Chinese. J Hum Hypertens 2006, 20:968–971.

    PubMed  Article  CAS  Google Scholar 

  45. Fan X, Wang Y, Sun K, et al.: Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women. Clin Pharmacol Ther 2007, 82:187–196.

    PubMed  Article  CAS  Google Scholar 

  46. Benjafield AV, Wang WY, Morris BJ: No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. Am J Hypertens 2004, 17:624–628.

    PubMed  Article  CAS  Google Scholar 

  47. Lieb W, Graf J, Götz A, et al.: Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy. J Mol Med 2006, 84:88–96.

    PubMed  Article  CAS  Google Scholar 

  48. Wakahara S, Konoshita T, Mizuno S, et al.: Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio. Endocrinology 2007, 148:2453–2457.

    PubMed  Article  CAS  Google Scholar 

  49. Joyner J, Neves LA, Granger JP, et al.: Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol 2007, 293:R169–R177.

    PubMed  CAS  Google Scholar 

  50. Gurley SB, Allred A, Le TH, et al.: Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest 2006, 116:2218–2225.

    PubMed  Article  CAS  Google Scholar 

  51. Ye M, Wysocki J, Rodriguez E, et al.: Recombinant ACE2 attenuates angiotensin II induced hypertension. Hypertension 2007, 50:LB10.

    Google Scholar 

Download references

Author information

Affiliations

  1. Division of Nephrology and Hypertension, Department of Medicine, The Feinberg School of Medicine, Northwestern University, 320 East Superior Street, Chicago, IL, 60611, USA

    Daniel Batlle

Authors
  1. Jan Wysocki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francisco R. González-Pacheco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel Batlle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Batlle.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wysocki, J., González-Pacheco, F.R. & Batlle, D. Angiotensin-converting enzyme 2: Possible role in hypertension and kidney disease. Current Science Inc 10, 70–77 (2008). https://doi.org/10.1007/s11906-008-0014-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-008-0014-1

Keywords

  • Ace2 Gene
  • Glomerular Injury
  • Ace2 Gene Polymorphism
  • Ace2 Knockout Mouse